๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Association between serum uric acid level and chronic liver disease in the United States

โœ Scribed by Anita Afzali; Noel S. Weiss; Edward J. Boyko; George N. Ioannou

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
236 KB
Volume
52
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis

Elevated serum uric acid (UA) levels strongly reflect and may even cause oxidative stress, insulin resistance, and metabolic syndrome, which are risk factors for the progression of liver disease. We sought to determine whether serum UA levels are associated with the development of cirrhosis or the presence of elevated serum liver enzymes. We used cohort data from the first National Health and Nutrition Examination Survey (NHANES I) to determine whether the baseline serum UA level was associated with the incidence of hospitalization or death due to cirrhosis among 5518 participants during a mean follow-up of 12.9 years (range 5 4-21 years) after the exclusion of the first 4 years of follow-up. We also used cross-sectional data from NHANES 1988-1994 (n 5 10,993) and NHANES 1999-2006 (n 5 6186) to determine whether the serum UA level was associated with elevated serum alanine aminotransferase (ALT) or c-glutamyl transferase (GGT), two markers of hepatic necroinflammation. Compared to persons in the lower third of the distribution of serum UA (<4.8 mg/dL), those in the top third (>6 mg/dL) had a higher risk of cirrhosisrelated hospitalization or death [adjusted hazard ratio (AHR) 5 2.8, 95% confidence interval (CI) 51.3-5.7], whereas the risk was not substantially increased in persons within the middle third (serum UA level 5 2.6-4.8 mg/dL, AHR 5 1.3, 95% CI 5 0.6-2.7). A higher serum UA level was associated with greater mean serum ALT and GGT levels and a greater probability of elevated serum ALT and GGT. Conclusion: The serum UA level is associated with the development of cirrhosis and the presence of elevated serum liver enzymes after adjustments for important causes and risk factors of chronic liver disease.

๐Ÿ“œ SIMILAR VOLUMES

Chronic liver disease mortality in the U
Chronic liver disease mortality in the United States, 1990โ€“1998
โœ Sirenda Vong; Beth P. Bell ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 179 KB

In 1998, chronic liver disease (CLD) was the tenth leading cause of death in the U.S. Alcohol and hepatitis C are thought to be important etiologies. However, traditional methods for calculating CLD mortality rates from death certificates may underestimate hepatitis C-related CLD mortality. We studi

Association between dietary nutrient com
Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the united states population
โœ George N. Ioannou; Olivia B. Morrow; Marah L. Connole; Sum P. Lee ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 130 KB

Little is known about the impact of dietary factors on the progression of liver disease. Our aim was to determine whether dietary intake was associated with the risk of cirrhosis-related or liver cancer-related death or hospitalization in the U.S. population. Participants included 9221 persons aged

The past incidence of hepatitis C virus
The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
โœ Gregory L. Armstrong; Miriam J. Alter; Geraldine M. McQuillan; Harold S. Margoli ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB ๐Ÿ‘ 1 views

Because chronic liver disease may develop many years after acute hepatitis C virus (HCV) infection, the past incidence of acute infections is a major determinant of the future burden of HCV-associated complications. We estimated past incidence of acute HCV infection using national seroprevalence dat